AllianceBernstein’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,956,087
| Closed | -$194M | – | 3205 |
|
|
2019
Q3 | $194M | Sell |
1,956,087
-61,728
| -3% | -$5.87M | 0.12% | 153 |
|
|
2019
Q2 | $187M | Sell |
2,017,815
-2,145,303
| -52% | -$204M | 0.12% | 162 |
|
|
2019
Q1 | $393M | Sell |
4,163,118
-110,087
| -3% | -$9.63M | 0.26% | 87 |
|
|
2018
Q4 | $274M | Buy |
4,273,205
+76,169
| +2% | +$5.62M | 0.2% | 104 |
|
|
2018
Q3 | $376M | Buy |
4,197,036
+231,231
| +6% | +$20.4M | 0.25% | 89 |
|
|
2018
Q2 | $315M | Buy |
3,965,805
+520,831
| +15% | +$43.2M | 0.22% | 101 |
|
|
2018
Q1 | $307M | Buy |
3,444,974
+316,946
| +10% | +$30.4M | 0.22% | 99 |
|
|
2017
Q4 | $326M | Buy |
3,128,028
+5,309
| +0.2% | +$599K | 0.23% | 98 |
|
|
2017
Q3 | $455M | Buy |
3,122,719
+10,617
| +0.3% | +$1.45M | 0.34% | 69 |
|
|
2017
Q2 | $404M | Sell |
3,112,102
-37,741
| -1% | -$4.62M | 0.31% | 75 |
|
|
2017
Q1 | $392M | Sell |
3,149,843
-33,533
| -1% | -$4.01M | 0.31% | 75 |
|
|
2016
Q4 | $368M | Sell |
3,183,376
-143,736
| -4% | -$16M | 0.31% | 72 |
|
|
2016
Q3 | $348M | Buy |
3,327,112
+325,653
| +11% | +$35.2M | 0.29% | 81 |
|
|
2016
Q2 | $296M | Buy |
3,001,459
+47,665
| +2% | +$4.93M | 0.25% | 88 |
|
|
2016
Q1 | $296M | Buy |
2,953,794
+22,014
| +0.8% | +$2.27M | 0.25% | 98 |
|
|
2015
Q4 | $351M | Buy |
2,931,780
+9,630
| +0.3% | +$1.11M | 0.3% | 76 |
|
|
2015
Q3 | $316M | Buy |
2,922,150
+271,101
| +10% | +$33.6M | 0.27% | 88 |
|
|
2015
Q2 | $307M | Sell |
2,651,049
-367,309
| -12% | -$42M | 0.25% | 93 |
|
|
2015
Q1 | $348M | Sell |
3,018,358
-313,431
| -9% | -$37.5M | 0.28% | 84 |
|
|
2014
Q4 | $373M | Sell |
3,331,789
-710,969
| -18% | -$75M | 0.31% | 80 |
|
|
2014
Q3 | $383M | Sell |
4,042,758
-357,412
| -8% | -$32.3M | 0.32% | 75 |
|
|
2014
Q2 | $378M | Sell |
4,400,170
-420,420
| -9% | -$32M | 0.32% | 71 |
|
|
2014
Q1 | $336M | Sell |
4,820,590
-1,940,714
| -29% | -$154M | 0.29% | 82 |
|
|
2013
Q4 | $571M | Buy |
6,761,304
+1,640,640
| +32% | +$130M | 0.51% | 40 |
|
|
2013
Q3 | $394M | Sell |
5,120,664
-212,856
| -4% | -$14.9M | 0.39% | 60 |
|
|
2013
Q2 | $312M | Buy |
+5,333,520
| New | +$321M | 0.33% | 77 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
AllianceBernstein's CELG Position: Q4 2019 in Review
AllianceBernstein sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,956,087 shares — an estimated $194M sold.
AllianceBernstein first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $571M in Q4 2013. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- AllianceBernstein reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- AllianceBernstein sold 1,956,087 Celgene Corp shares in Q4 2019, an estimated $194M.
- AllianceBernstein first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- AllianceBernstein's Celgene Corp position peaked at $571M in Q4 2013.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on AllianceBernstein's 13F filing for Q4 2019, filed 18 Feb 2020.